<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03120923</url>
  </required_header>
  <id_info>
    <org_study_id>HE551338</org_study_id>
    <nct_id>NCT03120923</nct_id>
  </id_info>
  <brief_title>Combined Corticosteroid With Low Volume Compared to High Volume in Impingement Syndrome</brief_title>
  <official_title>A Short Term Outcomes of Subacromial Injection of Combined Corticosteroid With Low Volume Compared to High Volume of Local Anesthetic for Rotator Cuff Impingement Syndrome: A Randomized Controlled Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramathibodi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess and compare the effectiveness of two different volumes of local
      anesthetic combined with 40mg of triamcinolone for subacromial injections in treating
      patients with rotator cuff impingement syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with rotator cuff impingement syndrome were randomized to undergo subacromial
      injection with 10mL total volume of 1% lidocaine plus 40mg triamcinolone acetonide (n = 22),
      or a 4mL total volume of 1% lidocaine plus 40-mg triamcinolone acetonide (n = 23).
      Evaluations using a visual analog scale (VAS) for pain during motion, and the Western Ontario
      Rotator Cuff Index (WORC) were completed before treatment and 30 minutes, 2 weeks, and 8
      weeks after injection.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">August 1, 2016</completion_date>
  <primary_completion_date type="Actual">August 1, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS</measure>
    <time_frame>8 weeks</time_frame>
    <description>Visual analog score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WORC</measure>
    <time_frame>8 weeks</time_frame>
    <description>Western Ontario Rotator Cuff Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse reaction</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Impingement Shoulder</condition>
  <arm_group>
    <arm_group_label>Lidocaine 3 cc &amp; Triamcinolone Acetonide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine 9cc &amp; Triamcinolone Acetonide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 3 cc</intervention_name>
    <arm_group_label>Lidocaine 3 cc &amp; Triamcinolone Acetonide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 9 cc</intervention_name>
    <description>9mL of 1% lidocaine plus 1mL of 40mg triamcinolone acetonide</description>
    <arm_group_label>Lidocaine 9cc &amp; Triamcinolone Acetonide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide</intervention_name>
    <arm_group_label>Lidocaine 3 cc &amp; Triamcinolone Acetonide</arm_group_label>
    <arm_group_label>Lidocaine 9cc &amp; Triamcinolone Acetonide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. participants with clinically diagnosed the rotator cuff impingement

          2. participants aged 20 years and older

          3. at least 1 month's duration

          4. pain of moderate to severe intensity, defined as a score of 5 or more points on a
             10-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain)

        Exclusion Criteria:

          1. patients with adhesive capsulitis of the shoulder (normal radiograph of affected
             shoulder, and restriction of passive motion &gt;30° in ≥2 planes of movement)

          2. previous trauma history at currently affected shoulder

          3. previous corticosteroid injection history at the affected shoulder

          4. abnormal calcification and/or primary osteoarthritis of the shoulder joint on plain
             radiographs

          5. use of medication such as antiplatelet agent or anticoagulation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2017</study_first_submitted>
  <study_first_submitted_qc>April 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2017</study_first_posted>
  <last_update_submitted>October 17, 2017</last_update_submitted>
  <last_update_submitted_qc>October 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Jatupon Kongtharvonskul</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>subacromial injection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

